Mega merger would disrupt Pfizer's AI transformation

“On Pfizer's first-quarter earnings call, CEO Albert Bourla was optimistic that in 2029, the company will begin a five-year period of strong growth, with revenue growth rates in the high…”

“Bourla said the company is planning to begin 20 pivotal studies this year and anticipates four regulatory decisions, calling 2026 "a pivotal year for R&D."”

“We intend to maintain and over time, grow our dividend as we continue to delever and build long-term value.”

“There has never been a trillion-dollar revenue business, and we may have two of them in the next 5-10 years.”

“has emerged as a significant business with a revenue run rate in the tens of billions of dollars and is now profitable in its own right”

“We’re going to invest to continue being the leader. We can fund this plan, and I think it will forever change the size of Amazon. It will forever change our revenue.”